InsiderClue
← All stocks

TransMedics Group, Inc.

TMDX Net buying
CIK 0001756262 #1701 in the set updated 17 Sep 2026
Bought (12 mo)
$1.11M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$4.87M
$0.00 on a plan · $3.98M straight out of an exercise
Sold at will
$891.95K
5 of 12 sales
Net
−$3.76M
+$217.46K against sales at will

By person

14 insiders · 14 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Hernandez Gerardo
Chief Financial Officer
—
$1.25M (4) scheduled
−$1.25M
31,935
0.0921%
$2.61M
—
Weill David
Director
$109.06K (1)
$1.22M (2) scheduled
−$1.11M
16,392
0.0473%
$1.34M
+52.7%
Hassanein Waleed H
President & CEO
$1.00M (1)
—
+$1.00M
666,102
1.92%
$54.37M
+25.4%
Gunderson Thomas J.
Director
—
$722.38K (1) scheduled
−$722.38K
16,642
0.0480%
$1.36M
+764.5%
Ranganath Anil P.
See remarks
—
$555.86K (2) scheduled
−$555.86K
13,091
0.0378%
$1.07M
+45.3%
Basile Edward M
Director
—
$540.32K (1) scheduled
−$540.32K
5,788
0.0167%
$472.47K
+690.7%
Corcoran Nicholas
See remarks
—
$412.63K (1)
−$412.63K
41,558
0.1198%
$3.39M
+96.9%
Lovell Stephanie
Director
—
$178.50K (1)
−$178.50K
5,788
0.0167%
$472.47K
+200.7%
Kania Edwin
Director
—
—
—
263,732
0.7606%
$21.53M
+2.0%
Khayal Tamer I
Chief Commercial Officer
—
—
—
36,042
0.1039%
$2.94M
+72.9%
Cecere Giovanni
Chief Commercial Officer
—
—
—
19,057
0.0550%
$1.56M
+139.0%
Forsyth Matthew S.
See Remarks
—
—
—
15,409
0.0444%
$1.26M
—
RAINES MERILEE
Director
—
—
—
6,981
0.0201%
$569.86K
+262.6%
TOBIN JAMES R
Director
—
—
—
6,981
0.0201%
$569.86K
−65.0%

Individual transactions

0

Nothing of that kind in this period.

What was left out

Form 4 filings counted 25
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 7
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 186,805
History held since 6 May 2019